Expression of BAFF and BR3 in patients with systemic lupus erythematosus
- PMID: 26840704
- PMCID: PMC4763815
- DOI: 10.1590/1414-431X20154853
Expression of BAFF and BR3 in patients with systemic lupus erythematosus
Abstract
The objective of this study was to examine the relationship between the expression of B cell activating factor (BAFF) and BAFF receptor in patients with disease activity of systemic lupus erythematosus (SLE). Real-time RT-PCR was used to examine BAFF mRNA expression in peripheral blood monocytes of active and stable SLE patients and healthy controls. The percentage of BAFF receptor 3 (BR3) on B lymphocytes was measured by flow cytometry. Soluble BAFF levels in serum were assayed by ELISA. Microalbumin levels were assayed by an automatic immune analysis machine. BAFF mRNA and soluble BAFF levels were highest in the active SLE group, followed by the stable SLE group, and controls (P<0.01). The percentage of BR3 on B lymphocytes was downregulated in the active SLE group compared with the stable SLE group and controls (P<0.01). BAFF mRNA levels and soluble BAFF levels were higher in patients who were positive for proteinuria than in those who were negative (P<0.01). The percentage of BR3 on B lymphocytes was lower in patients who were positive for proteinuria than in those who were negative (P<0.01). The BAFF/BR3 axis may be over-activated in SLE patients. BAFF and BR3 levels may be useful parameters for evaluating treatment.
Figures



Similar articles
-
Expression of B-cell activating factor of the tumour necrosis factor family (BAFF) in T cells in active systemic lupus erythematosus: the role of BAFF in T cell-dependent B cell pathogenic autoantibody production.Rheumatology (Oxford). 2007 Jul;46(7):1083-6. doi: 10.1093/rheumatology/kem097. Epub 2007 May 11. Rheumatology (Oxford). 2007. PMID: 17500077
-
Investigations of a rabbit (Oryctolagus cuniculus) model of systemic lupus erythematosus (SLE), BAFF and its receptors.PLoS One. 2009 Dec 30;4(12):e8494. doi: 10.1371/journal.pone.0008494. PLoS One. 2009. PMID: 20041151 Free PMC article.
-
Expressions of BAFF/BAFF receptors and their correlation with disease activity in Chinese SLE patients.Lupus. 2010 Nov;19(13):1534-49. doi: 10.1177/0961203310375268. Lupus. 2010. PMID: 20974656
-
Does the BAFF dysregulation play a major role in the pathogenesis of systemic lupus erythematosus?J Autoimmun. 2008 Feb-Mar;30(1-2):63-7. doi: 10.1016/j.jaut.2007.11.001. Epub 2007 Dec 21. J Autoimmun. 2008. PMID: 18155417 Review.
-
BAFF and innate immunity: new therapeutic targets for systemic lupus erythematosus.Immunol Cell Biol. 2012 Mar;90(3):293-303. doi: 10.1038/icb.2011.111. Epub 2012 Jan 10. Immunol Cell Biol. 2012. PMID: 22231653 Review.
Cited by
-
BAFF Blockade Attenuates Inflammatory Responses and Intestinal Barrier Dysfunction in a Murine Endotoxemia Model.Front Immunol. 2020 Nov 26;11:570920. doi: 10.3389/fimmu.2020.570920. eCollection 2020. Front Immunol. 2020. PMID: 33324396 Free PMC article.
-
B cell-activating factor (BAFF) from dendritic cells, monocytes and neutrophils is required for B cell maturation and autoantibody production in SLE-like autoimmune disease.Front Immunol. 2023 Feb 27;14:1050528. doi: 10.3389/fimmu.2023.1050528. eCollection 2023. Front Immunol. 2023. PMID: 36923413 Free PMC article.
-
IFN-I Mediates Dysfunction of Endothelial Progenitor Cells in Atherosclerosis of Systemic Lupus Erythematosus.Front Immunol. 2020 Nov 11;11:581385. doi: 10.3389/fimmu.2020.581385. eCollection 2020. Front Immunol. 2020. PMID: 33262760 Free PMC article. Review.
-
High BAFF expression associated with active disease in systemic lupus erythematosus and relationship with rs9514828C>T polymorphism in TNFSF13B gene.Clin Exp Med. 2019 May;19(2):183-190. doi: 10.1007/s10238-019-00549-8. Epub 2019 Feb 11. Clin Exp Med. 2019. PMID: 30747361
-
Potential for Antigen-Specific Tolerizing Immunotherapy in Systematic Lupus Erythematosus.Front Immunol. 2021 Jul 16;12:654701. doi: 10.3389/fimmu.2021.654701. eCollection 2021. Front Immunol. 2021. PMID: 34335564 Free PMC article. Review.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical